In bed with big PhRMA

I suspect many in the U.S. are unaware of the fact that we are currently in the process of negotiating what the Office of the United States Trade Representative (“USTR”) characterizes as an “ambitious, next-generation, Asia-Pacific trade agreement” with Australia, Brunei Darussalam, Chile, Malaysia, New Zealand, Peru, Singapore, and Vietnam—the Trans-Pacific Partnership (“TPP”). This past week, the parties engaged in an “intersessional” round of negotiations here in Santiago regarding the proposed intellectual property provisions. I attended a fascinating conference on Thursday at the Universidad Católica—which originally had been scheduled to take place at the Universidad de Chile, but was moved at the last minute. The panel participants generally confirmed my belief that the USTR has adopted the agendas of certain powerful interest groups—including big PhRMA—as the official U.S. position.

Continue reading